| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $86K | — | — |
| R&D Expense | $321K | -85.9% | -88.3% |
| SG&A Expense | $3.7M | -21.0% | +64.3% |
| Operating Income | -$4.0M | +42.1% | +19.1% |
| Pre-tax Income | -$3.9M | +40.5% | +2.1% |
| Net Income | -$3.9M | +40.5% | +2.1% |
| EPS (Basic) | -$0.35 | -1650.0% | -75.0% |
| EPS (Diluted) | -$0.35 | -1650.0% | -75.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.5M | +8.1% | +1009.4% |
| Current Assets | $80.1M | +7.3% | +412.5% |
| Total Assets | $80.3M | +7.0% | +395.7% |
| Current Liabilities | $1.9M | +24.6% | -73.8% |
| Total Liabilities | $5.0M | +215.6% | -42.6% |
| Stockholders' Equity | $75.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.2M | — | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$64K | — | — |
| Financing Cash Flow | $72.8M | — | — |
| Free Cash Flow | -$16.3M | — | — |
| +916.3% |